These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38910715)
21. Using methotrexate to treat patients with ENL unresponsive to steroids and clofazimine: a report on 9 patients. Hossain D Lepr Rev; 2013 Mar; 84(1):105-12. PubMed ID: 23741889 [TBL] [Abstract][Full Text] [Related]
22. The role of thalidomide in the management of erythema nodosum leprosum. Walker SL; Waters MF; Lockwood DN Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771 [TBL] [Abstract][Full Text] [Related]
23. Thalidomide and steroid in the management of erythema nodosum leprosum. P K Mishra SR; Samal R; Behera B Indian J Pharmacol; 2022; 54(3):177-182. PubMed ID: 35848688 [TBL] [Abstract][Full Text] [Related]
24. New Insight into the Pathogenesis of Erythema Nodosum Leprosum: The Role of Activated Memory T-Cells. Negera E; Bobosha K; Walker SL; Endale B; Howe R; Aseffa A; Dockrell HM; Lockwood DN Front Immunol; 2017; 8():1149. PubMed ID: 28966621 [TBL] [Abstract][Full Text] [Related]
25. Apremilast in chronic recalcitrant erythema nodosum leprosum: a report of two cases. Narang T; Kaushik A; Dogra S Br J Dermatol; 2020 Apr; 182(4):1034-1037. PubMed ID: 31218666 [TBL] [Abstract][Full Text] [Related]
26. Whole blood transcriptomics reveals the enrichment of neutrophil activation pathways during erythema nodosum leprosum reaction. Rosa TLSA; Leal-Calvo T; Tavares IF; Mendes MA; Dias AA; Piauy MHDS; Barboza MFDS; Kapuscinski M; Costa FDMR; Marques MAM; Belone AFF; Sales AM; Hacker MA; Moreira MBP; Belisle JT; Moraes MO; Pessolani MCV; Schmitz V Front Immunol; 2024; 15():1366125. PubMed ID: 38715615 [TBL] [Abstract][Full Text] [Related]
27. Azathioprine in Chronic Recalcitrant Erythema Nodosum Leprosum: A Case Report. Jitendra SSV; Bachaspatimayum R; Devi AS; Rita S J Clin Diagn Res; 2017 Aug; 11(8):FD01-FD02. PubMed ID: 28969152 [TBL] [Abstract][Full Text] [Related]
29. Erythema nodosum leprosum on glans penis: unusual manifestation of common disease. Kothiwala SK; Khandpur S; Singh MK; Durgapal P Int J Dermatol; 2015 Sep; 54(9):1060-3. PubMed ID: 25557912 [TBL] [Abstract][Full Text] [Related]
30. Case Report: A Case Series of Immunobiological Therapy (Anti-TNF-α) for Patients With Erythema Nodosum Leprosum. Mendes AFM; Gomes CM; Kurizky PS; Ianhez M Front Med (Lausanne); 2022; 9():879527. PubMed ID: 35814767 [TBL] [Abstract][Full Text] [Related]
31. Rare atypical presentations in Type 2 lepra reaction: a case series. Vijendran P; Verma R; Vasudevan B; Mitra D; Badad A; Neema S Int J Dermatol; 2014 Mar; 53(3):323-6. PubMed ID: 24134145 [TBL] [Abstract][Full Text] [Related]
32. Methotrexate in erythema nodosum leprosum: Pitfalls to avoid. Mehta H; Narang T; Dogra S; Kumar B Trop Doct; 2022 Jan; 52(1):226-227. PubMed ID: 34787533 [TBL] [Abstract][Full Text] [Related]
33. Increased activated memory B-cells in the peripheral blood of patients with erythema nodosum leprosum reactions. Negera E; Walker SL; Bekele Y; Dockrell HM; Lockwood DN PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006121. PubMed ID: 29253897 [TBL] [Abstract][Full Text] [Related]
34. [Effectiveness of thalidomide for erythema nodosum leprosum (ENL): retrospective study of 20 Japanese cases in National Sanatrium Oku-Komyoen]. Matsuki T; Okano Y; Aoki Y; Ishida Y; Hatano K; Kumano K Nihon Hansenbyo Gakkai Zasshi; 2014 Dec; 83(3):1-6. PubMed ID: 25826849 [TBL] [Abstract][Full Text] [Related]
35. Case report: Cyclophosphamide pulse therapy for chronic recalcitrant erythema nodosum leprosum. Machado GU; Amparo T; Bulhões F; Machado PRL Front Med (Lausanne); 2023; 10():1272404. PubMed ID: 38020095 [TBL] [Abstract][Full Text] [Related]
36. Necrotic erythema nodosum leprosum with oral mucosal involvement. Swain JP; Soud A; Agarwal SK Indian J Lepr; 2008; 80(2):175-8. PubMed ID: 19425513 [TBL] [Abstract][Full Text] [Related]
37. Concomitant lucio phenomenon and erythema nodosum in a leprosy patient: clues for their distinct pathogeneses. Benard G; Sakai-Valente NY; Bianconcini Trindade MA Am J Dermatopathol; 2009 May; 31(3):288-92. PubMed ID: 19384072 [TBL] [Abstract][Full Text] [Related]
38. The mortality associated with erythema nodosum leprosum in Ethiopia: a retrospective hospital-based study. Walker SL; Lebas E; Doni SN; Lockwood DN; Lambert SM PLoS Negl Trop Dis; 2014 Mar; 8(3):e2690. PubMed ID: 24625394 [TBL] [Abstract][Full Text] [Related]
39. The effect of anti-reactional drugs on complement components in the type II, erythema nodosum leprosum, reaction. Sehgal VN; Sharma V; Sharma VK Br J Dermatol; 1988 Aug; 119(2):255-8. PubMed ID: 3166944 [TBL] [Abstract][Full Text] [Related]
40. A Case of Lepromatous Leprosy With Erythema Nodosum Leprosum. Park L; Wallace CE; Vasile G; Buckley C Cureus; 2023 Jan; 15(1):e33846. PubMed ID: 36819324 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]